Inso Bio is an early-stage startup developing sample prep platforms for genomic analysis. We are exploring applications in long-read sequencing & metagenomics.
Going to #ABRF2024? Visit our team at Booth #606 to learn more about how @InsoBiosciences can help you automate your High Molecular Weight (HMW) DNA extractions for your lab's Long Read sequencing workflows!
@InsoBiosciences has been awarded a Phase I SBIR for $175,000 from the The United States Department of Agriculture (@USDA) to begin development of our technology platform towards applications in long-read sequencing for agrigenomics! 🌽🌱🔬
Happy Holidays, and cheers! This year we had a lot of fun creating our team via custom LEGOs! (Holiday hats not included!)
Interested in finding out more about working at @InsoBiosciences? Reach out to us at [email protected] to get in touch!
#holidays2022#SeasonsGreetings
Visiting @Cornell University campus? Come check out our work display! Thank you to the Cornell’s microfabrication center, Cornell NanoScale Facility, for selecting our work to feature in your center's showcase shelves!
#sampleprep#genomics#microfabrication#microfluidics
Tune in to hear our founder, @HarveyCTian, discusses how @InsoBiosciences is changing #genomics with #sampleprep on the Startup Growth Engine podcast.
(Streaming Links Below!👇)
https://t.co/JYm0CZQFMX
Thank you @cornellsun for helping the communities of @Cornell and Ithaca better understand how local biotech startups are using NY state resources and novel technologies to solve biodefense challenges!
Two @Indbio NY and also @Cornell alums, @HalomineInc @InsoBiosciences, won New York State Biodefense Commercialization Fund grants to help make sure the next pandemic 😷 goes better than the last one.
https://t.co/pkKTPvTmHe
Our afternoon sessions kick-off with Harvey Tian from @InsoBiosciences discussing the efforts into growing life science companies in NYS ##NYSIS22#LifeSciences
Great to see @indbio NY innovative companies @HalomineInc & @InsoBiosciences tackling current & future infectious diseases
#NY#biotech#lifescience
Cornell startups get $3M from NYS to impede disease outbreak https://t.co/9A60PIrWgG
In collaboration with researchers at @WeillCornell, @InsoBiosciences has been awarded a Phase I contract of $400,000 from the @NIH and @NCIgenomics (NCI) to develop our technology system towards applications in single cell multi-omic sample processing for cancer genomics!
CDL-Toronto Health graduate @InsoBiosciences has developed a device that extracts undamaged, intact DNA from biological samples, a requisite for long-read genome sequencing. #CDLSuperSession
https://t.co/XX0sgEZBxu
Thank you @GenomeWeb for featuring our @Cornell University origin story with our co-founder, Professor Emeritus Harold Craighead!
We are immensely proud of our Cornell beginnings, and "Go Big Red!"
Article Link: https://t.co/tkSKOvY9jq
1/A couple exciting @Whitecapvp announcements today:
- We took part in a $2.2M seed round with @HarveyCTian and his company @InsoBiosciences. Led by our friends @2048vc, we think Inso can revolutionize sample prep in the long read gene sequencing space.
https://t.co/CXVMYzJgwf
1. We are thrilled to announce our latest investment in @InsoBiosciences !
Inso Biosciences aims to make genomics more accessible by creating an automated genomic DNA processing machine.
Read more about why we invested 👇
https://t.co/tk7SAoS4Zk
2. A few details about the company:
👩💻 The Founders: @HarveyCTian , Adam Bisogni, & Harold Craighead
📌 Location: New York
💰 Investment Stage: Pre-seed
Are you going to the inaugural AGBT-Agricultural Genomics Conference next week? If so, we would love to have you come by our poster and chat with us!
#longread#sequencing#sampleprep#agriculture
https://t.co/9LYHo1dtlF
We have officially joined the 2048 Ventures family, and we are excited to be working with stellar folks, including Alex Iskold and Julie Wolf! To find out more about our journey thus far and next steps, check out this blog post on 2048's blog!
https://t.co/9mbj9dPmMX
We are elated to announce that Inso Biosciences has become venture-backed with the closing of an oversubscribed $2.2M pre-seed round led by 2048 Ventures with participation from SOSV, Whitecap Venture Partners, Ataraxia Partners, and CRCM Ventures!
https://t.co/HseH7WJJTG